Off-label and unlicensed drug use in neonatal intensive care units in Turkey: The old-inn study

International Journal of Clinical Pharmacy

Volumn 34, Issue 1, 2012, Pages 136-141

  Oguz, S Suna ^a   Kanmaz, H Gozde ^a   Dilmen, Ugur ^a  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

Author keywords

Neonates; Off label drug; Turkey; Unlicensed drug

Indexed keywords

AMIKACIN; AMPICILLIN; CAFFEINE CITRATE; MEROPENEM; MULTIVITAMIN; NETILMICIN; NYSTATIN; PENICILLIN G; THEOPHYLLINE; VANCOMYCIN; PRESCRIPTION DRUG;

ARTICLE; AWARENESS; DRUG USE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TURKEY (REPUBLIC); CLINICAL PRACTICE; COHORT ANALYSIS; DRUG APPROVAL; LEGAL ASPECT; OFF LABEL DRUG USE; STATISTICS;

COHORT STUDIES; DRUG APPROVAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; TURKEY;

EID: 84860826352     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9604-0     Document Type: Article

References (31)

1. Turkish Population and Health Survey Reports 1998 and 2008. Turkish Statistical Institute (TURKSTAT). www.turkstat.gov.tr.
2. van den Anker JN. Managing drugs safely. Semin Fetal Neonatal Med. 2005;10(1):73-81.
3. Rx MediaPharma 2010. Levent Ustünbaş, editor. Interaktif ilaçbilgi kaynaǧi. www.eczanet.com.
4. Taketemo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. 11th ed. Ohio: Lexi-Comp's; 2004. ISBN1-59195-093-7.
5. Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. Unlicensed and off-label use of medicines at a neona-tology clinic in Italy. Pharm World Sci. 2007;29(4):361-7.
6. Dick A, Keady S, Mohamed F, Brayley S, Thomson M, Lloyd BW, Heuschkel R, Afzal NA. Use of unlicensed and off-label medications in pediatric gastroenterology with a review of the commonly used formularies in the UK. Aliment Pharmacol Ther. 2003;17:571-5.
7. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in pediatric wards in European countries. European network for drug investigation in children. Br Med J. 2000;320(7227):79-82.
8. Craig JS, Henderson CR, Magee FA. The extent of unlicensed and off-label drug use in the pediatric ward of a district general hospital in Northern Ireland. Ir Med J. 2001;94(8):237-40.
9. Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161(3): 282-90.
10. Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Läer S. Off-label drug use among hospitalized children: identifying areas with the highest need for research. Pharm World Sci. 2008;30(5):497-502.
11. Morales-Carpi C, Estañ L, Rubio E, Lurbe E, Morales-Olivas FJ. Drug utilization and off-label drug use among Spanish emergency room pediatric patients. Eur J Clin Pharmacol. 2010;66(3): 315-20.
12. Chalumeau M, Tréluyer JM, Salanave B, Assathiany R, Chéron G, Crocheton N, Rougeron C, Mares M, Bréart G, Pons G. Off label and unlicensed drug use among French office based pediatricians. Arch Dis Child. 2000;83(6):502-5.
13. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164:552-8.
14. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodi-ferro D, Solarino B, Quaranta R, Dell'Erba AS. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2007;29(4):361-7.
15. Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr. 2000;7(2):143-7.
16. Barr J, Brenner-Zada G, Heiman E, Pareth G, Bulkowstein M, Greenberg R, Berkovitch M. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol. 2002;19(2):67-72.
17. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80(2): F142-4.
18. Arda B, Kavas V, Demirkazik A, Akbulut H. What can we say about off-label drug use in oncology in the light of ethics? TK Tip Etiǧi Hukuku Tarihi Dergisi. 2003;11(4):249-52.
19. Cakmak HB, Demir M, Buken NO. Ethical evaluation of off-label use in Turkey: Bevacizumab as an example. J Retina-Vitreous. 2008;16(4):311-5.
20. Kockaya G, Polat M, Vural IM, et al. Off-label and unlicensed oncology medicine use in Turkey: a retrospective analysis of computer records of the Turkish Ministry of Health. J Pharm Health Serv Res. 2011;2(1):53-7.
21. Stewart D, Rouf A, Snaith A, et al. Attitudes and experiences of community pharmacists towards pediatric off-label prescribing: a prospective survey. Br J Clin Pharmacol. 2007;64(1):90-5.
22. Neubert A, Wong IC, Bonifazi A, et al. Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res. 2008;58(5-6):316-22.
23. Sherwin CM, Svahn S, Van der Linden A, et al. Individualized dosing of amikacin in neonates: a pharmacokinetic/pharmaco-dynamic analysis. Eur J Clin Pharmacol. 2009;65(7):705-13.
24. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011;158(4):549-54.
25. Brion F, Nunn AJ, Rieutord A. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr. 2003;92:486-90.
26. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: from neonates to adolescents. Adv Drug Deliv Rev. 2006;58(1):4-14.
27. Beggs SA, Cranswick NE, Reed MD. Improving drug use for children in the developing world. Arch Dis Child. 2005;90:1091-3.
28. Hill P. Off license and off label prescribing in children: litigation fears for physicians. Arch Dis Child. 2005;90(Suppl I):i17-8.
29. Pharmaceutical and Medical Preparations Law. Law No: 1262 Acceptance Date: 14th, 1928.
30. Turkish Medical Deontology Regulation. Law No: 4/12578, Acceptance Date: 13th Jan, 1960.
31. Off-Labeled use of Drug Regulation. Circular numbered 115-2006.